INTIMATION OF SCHEDULE OF ANALYST / INSTITUTIONAL INVESTOR MEETING
Awaiting price reaction for this filing.
Eris Lifesciences Limited has informed the stock exchanges about an upcoming virtual meeting with JP Morgan India Private Limited on Thursday, May 15, 2025. The meeting falls under the 'Investor Group' category and will be conducted online. The company has clarified that no unpublished price-sensitive information (UPSI) will be shared during the interaction, and discussions will be based only on publicly available documents. The filing was made on May 5, 2025, in compliance with SEBI's Listing Obligations and Disclosure Requirements Regulations, 2015.
This is a routine regulatory disclosure about an investor engagement and is unlikely to cause any immediate stock price movement, as no new or sensitive information is being shared. However, it signals continued institutional interest in Eris Lifesciences.